Feed aggregator

(Reuters) - The Food and Drug Administration has approved Johnson & Johnson's drug Simponi for patients with moderate to severe ulcerative colitis, an inflammatory disease affecting the colon. Simponi is already approved to treat rheumatoid ar...

WASHINGTON (Reuters) - President Barack Obama will deliver a statement on the controversy surrounding the Internal Revenue Service's targeting of conservative groups, the White House said on Wednesday. The president is set to speak at 6 p.m. H...

By Sharon Begley NEW YORK (Reuters) - Scientists' assertion that the advance in therapeutic cloning announced on Wednesday could not and would not pave the way to cloning a baby did little to assuage critics of the research. The research &quot...

NEW YORK (AP) — Global health officials say a deadly new respiratory virus related to SARS has apparently spread from patients to two health care workers in eastern Saudi Arabia.

sisterhearts: @katieraml, looking forward to your heart healthy tweets... love your #Rally4Red program to prevent #heart disease http://t.co/bkHnWTisr0

sisterhearts: @sisterhearts is looking for bloggers to join our global heart blogger network & share their personal health journeys http://t.co/gWZd2gqiul

OTTAWA (Reuters) - The Canadian province of Quebec, citing public concerns, unveiled a bill on Wednesday to impose a moratorium on hydraulic fracturing, known as fracking, in a region rich in shale gas deposits. The province's minority Parti Q...

SAN FRANCISCO (AP) — When Liz DeRouen needs any kind of health care services, from diabetes counseling to a dental cleaning, she checks into a government-funded clinic in Northern California's wine country that covers all her medical needs.

By Tom Miles GENEVA (Reuters) - People are living longer than ever and "dramatic" gains in life expectancy show no sign of slowing down, the World Health Organization said on Wednesday. "The global life expectancy has increased from...

By Jessica Toonkel NEW YORK (Reuters) - Before Optimer Pharmaceuticals Inc even put itself up for sale earlier this year, Cubist Pharmaceuticals Inc offered to buy the antibiotic maker for $20 per share, or nearly $1 billion, two people familiar w...

By Jessica Toonkel NEW YORK (Reuters) - Swiss drugmaker Roche Holding AG is exploring a sale of its blood glucose meters business, three people familiar with the matter told Reuters on Wednesday, as the industry grapples with increased competition...

By Andrew M. Seaman NEW YORK (Reuters Health) - Despite a strong warning from U.S. regulators in 2007, for-profit dialysis centers still gave their kidney failure patients more of a certain anemia drug than non-profit centers in 2008, says a new s...

By Genevra Pittman NEW YORK (Reuters Health) - Music, art and dance therapy may relieve anxiety and similar symptoms among people with cancer, according to a new analysis of past studies. Researchers who analyzed results from trials conducted betw...

By Jeanine Prezioso NEW YORK (Reuters) - Enbridge Energy Partners said it may be forced to shut down an 80,000 barrel-per-day (bpd) oil-loading rail terminal in North Dakota unless the amount of potentially deadly hydrogen sulfide in crude oil del...

CHICAGO (AP) — In the new psychiatric manual of mental disorders, grief soon after a loved one's death can be considered major depression. Extreme childhood temper tantrums get a fancy name. And certain "senior moments" are called &q...

By Kerry Grens NEW YORK (Reuters Health) - Children with even slightly elevated blood lead levels are less likely to be ready to read when starting kindergarten, according to a new study. Lead has been shown to affect school performance, but what&...

By Dave Warner and Daniel Kelley PHILADELPHIA (Reuters) - A Philadelphia doctor was sent to prison on Wednesday to serve three life terms without parole for murdering babies during late-term abortions and other crimes at his squalid clinic. In a d...

There has been very good news recently regarding the lowering of the death rate of heart disease.

Wonderful!

However, it is still the number one killer of women worldwide; in fact, it is still the number one killer of all diseases! So while we have made incredible advances in knowledge of how to treat heart disease we have not done a great job in prevention.

Which is so interesting!   We know more about prevention than ever before yet people are just not doing it!   So what to do?

Well, my organization, the Sister to Sister Foundation (www.sistertosister.org) , along with Brigham and Women’s Hospital, have created a wellness program on our web-site called Smart for the Heart. We are already reaching over twenty thousand women a month but our goal is way larger. This is a way for anyone, anywhere in the world, get to know their risk, learn what to do about it and then follow up with the latest knowledge.

And, we are currently working on making it as much fun as our health fairs. Also, some surprises! I can’t tell you about the latest idea but I guarantee it is fun. I will tell you that it is not new to Sister to Sister but “she” may surface in another way!

We have added some new partners that we are quite proud of. I may have told you about Hadassah Hospital in Jerusalem which is fantastic. Already within a few months they have screened hundreds of women and over five hundred Arab women! We are very proud of that!

Other new partners are Johns Hopkins Ciccarone Center with Dr. Roger Blumenthal who I have worked with for over eight years; and Cedars Sinai Women’s Heart Center with Dr. Noel Bairey-Merz, also someone I have worked with for the same period.

I am so proud that we have these outstanding partners as we move forward on increasing prevention of heart disease.

WASHINGTON (AP) — President Barack Obama is planning a mental health conference next month in response to gun violence.

By Kathryn Doyle NEW YORK (Reuters Health) - Ovarian cancer rates in the U.S. began to decline faster in 2002 around the time many older women went off hormone replacement therapy, according to a new study. That year, the Women's Health Initia...